• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Regional variations in patient selection and procedural characteristics for cryoballoon ablation of atrial fibrillation in the cryo global registry.冷冻全球注册研究中冷冻球囊消融治疗心房颤动的患者选择和手术特征的地域差异。
J Interv Card Electrophysiol. 2024 Apr;67(3):493-501. doi: 10.1007/s10840-023-01582-0. Epub 2023 Jul 28.
2
Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry.冷冻球囊与射频消融治疗心房颤动的比较:基于 ESC-EHRA 心房颤动消融长期注册登记研究和瑞典导管消融注册登记研究的结局和安全性分析。
Europace. 2019 Apr 1;21(4):581-589. doi: 10.1093/europace/euy239.
3
Comparison of the PolarX and the Arctic Front cryoballoon for pulmonary vein isolation in patients with symptomatic paroxysmal atrial fibrillation (COMPARE CRYO) - Study protocol for a randomized controlled trial.用于有症状阵发性心房颤动患者肺静脉隔离的PolarX与北极锋冷冻球囊的比较(COMPARE CRYO)——一项随机对照试验的研究方案
Contemp Clin Trials. 2023 Nov;134:107341. doi: 10.1016/j.cct.2023.107341. Epub 2023 Sep 16.
4
Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project.肺静脉隔离冷冻消融治疗持续性和长程持续性心房颤动患者:真实世界多中心观察性研究的临床结果。
Heart Rhythm. 2018 Mar;15(3):363-368. doi: 10.1016/j.hrthm.2017.10.038. Epub 2017 Oct 26.
5
Cryoballoon Versus Laserballoon: Insights From the First Prospective Randomized Balloon Trial in Catheter Ablation of Atrial Fibrillation.冷冻球囊与激光球囊:导管消融治疗心房颤动的首次前瞻性随机球囊试验的新见解。
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009294. doi: 10.1161/CIRCEP.120.009294. Epub 2021 Jan 8.
6
Pulmonary vein isolation by means of a novel cryoballoon technology in paroxysmal atrial fibrillation patients: 1-year outcome from a large Italian multicenter clinical registry.新型冷冻球囊技术在阵发性心房颤动患者中肺静脉隔离的 1 年结果:来自意大利大型多中心临床注册研究。
Pacing Clin Electrophysiol. 2023 Nov;46(11):1302-1309. doi: 10.1111/pace.14839. Epub 2023 Oct 17.
7
Impact of 3D mapping on procedural characteristics and outcomes in cryoballoon pulmonary vein isolation for atrial fibrillation.三维标测对心房颤动冷冻球囊肺静脉隔离术操作特征及结果的影响
J Interv Card Electrophysiol. 2018 Jan;51(1):71-75. doi: 10.1007/s10840-017-0304-0. Epub 2018 Jan 5.
8
Pulmonary vein isolation using cryoballoon ablation versus RF ablation using ablation index following the CLOSE protocol: A prospective randomized trial.使用冷冻球囊消融与按照CLOSE方案使用消融指数进行射频消融的肺静脉隔离:一项前瞻性随机试验。
J Cardiovasc Electrophysiol. 2022 May;33(5):866-873. doi: 10.1111/jce.15383. Epub 2022 Mar 14.
9
Cryoballoon ablation for atrial fibrillation in South Africa: One-year outcome from the Cryo Global Registry.南非的冷冻球囊消融治疗心房颤动:Cryo Global 注册研究的一年结果。
S Afr Med J. 2024 Mar 18;114(3):e1338. doi: 10.7196/SAMJ.2024.v114i3.1338.
10
Twelve-month efficacy of second-generation cryoballoon ablation for atrial fibrillation performed at community hospitals: results of the German register on cryoballoon ablation in local hospitals (regional).社区医院行第二代冷冻球囊消融治疗心房颤动的 12 个月疗效:德国社区医院冷冻球囊消融登记研究(区域性)结果。
J Interv Card Electrophysiol. 2023 Mar;66(2):417-425. doi: 10.1007/s10840-022-01331-9. Epub 2022 Aug 13.

引用本文的文献

1
Long-term Outcome of Cryoballoon Ablation in Korean Patients With Atrial Fibrillation: Real-World Experience From the Cryo Global Registry.韩国房颤患者冷冻球囊消融的长期结局:来自冷冻全球注册研究的真实世界经验
Korean Circ J. 2024 Oct;54(10):619-633. doi: 10.4070/kcj.2024.0044. Epub 2024 Jun 10.
2
Incidence of phrenic nerve injury during pulmonary vein isolation using different cryoballoons: data from a large prospective ablation registry.不同冷冻球囊行肺静脉隔离术时膈神经损伤的发生率:来自大型前瞻性消融登记研究的数据。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae092.

本文引用的文献

1
Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global Registry.一线冷冻消融治疗心房颤动对医疗利用、心律失常疾病负担及疗效结果的影响:来自冷冻全球注册研究的真实世界证据
J Interv Card Electrophysiol. 2023 Apr;66(3):711-722. doi: 10.1007/s10840-022-01388-6. Epub 2022 Nov 4.
2
Twelve-month efficacy of second-generation cryoballoon ablation for atrial fibrillation performed at community hospitals: results of the German register on cryoballoon ablation in local hospitals (regional).社区医院行第二代冷冻球囊消融治疗心房颤动的 12 个月疗效:德国社区医院冷冻球囊消融登记研究(区域性)结果。
J Interv Card Electrophysiol. 2023 Mar;66(2):417-425. doi: 10.1007/s10840-022-01331-9. Epub 2022 Aug 13.
3
Second versus fourth generation of cryoballoon catheters: The 1STOP real-world multicenter experience.第二代与第四代冷冻球囊导管:1STOP 真实世界多中心经验。
Pacing Clin Electrophysiol. 2022 Aug;45(8):968-974. doi: 10.1111/pace.14494. Epub 2022 May 2.
4
Phrenic Nerve Injury During Cryoballoon-Based Pulmonary Vein Isolation: Results of the Worldwide YETI Registry.冷冻球囊导管肺静脉隔离术中膈神经损伤:全球 YETI 注册研究结果。
Circ Arrhythm Electrophysiol. 2022 Jan;15(1):e010516. doi: 10.1161/CIRCEP.121.010516. Epub 2021 Dec 28.
5
Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting: Results from the Cryo AF Global Registry.在真实全球环境中冷冻球囊消融治疗阵发性和持续性房颤的安全性与有效性:冷冻房颤全球注册研究结果
J Arrhythm. 2021 Jan 25;37(2):356-367. doi: 10.1002/joa3.12504. eCollection 2021 Apr.
6
Surveys and Registries on Catheter Ablation of Atrial Fibrillation: Fifteen Years of History.房颤导管消融的调查和注册研究:十五年历史回顾。
Circ Arrhythm Electrophysiol. 2021 Jan;14(1):e008073. doi: 10.1161/CIRCEP.120.008073. Epub 2021 Jan 14.
7
Procedure characteristics and outcomes of atrial fibrillation ablation procedures using cryoballoon versus radiofrequency ablation: A report from the GWTG-AFIB registry.使用冷冻球囊与射频消融治疗心房颤动的手术特点和结果:来自 GWTG-AFIB 注册研究的报告。
J Cardiovasc Electrophysiol. 2021 Feb;32(2):248-259. doi: 10.1111/jce.14858. Epub 2021 Jan 6.
8
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
9
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial.冷冻球囊消融肺静脉治疗持续性心房颤动:多中心 STOP Persistent AF 试验结果。
Heart Rhythm. 2020 Nov;17(11):1841-1847. doi: 10.1016/j.hrthm.2020.06.020. Epub 2020 Jun 24.
10
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.连续监测评估的冷冻球囊或射频消融治疗心房颤动:一项随机临床试验。
Circulation. 2019 Nov 26;140(22):1779-1788. doi: 10.1161/CIRCULATIONAHA.119.042622. Epub 2019 Oct 21.

冷冻全球注册研究中冷冻球囊消融治疗心房颤动的患者选择和手术特征的地域差异。

Regional variations in patient selection and procedural characteristics for cryoballoon ablation of atrial fibrillation in the cryo global registry.

机构信息

Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Medical University of Lodz, Łódź, Poland.

出版信息

J Interv Card Electrophysiol. 2024 Apr;67(3):493-501. doi: 10.1007/s10840-023-01582-0. Epub 2023 Jul 28.

DOI:10.1007/s10840-023-01582-0
PMID:37505337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11016010/
Abstract

BACKGROUND

Cryoballoon ablation is a well-established anatomical approach for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF). Although widely adopted, regional variations in standards of care have not been well characterized.

METHODS

Patients with AF were enrolled in the Cryo Global Registry (NCT02752737) from May 2016 to Sept 2021 at 128 sites in 37 countries and treated with cryoballoon ablation according to local clinical practice. Baseline patient and procedural characteristics were summarized for 8 regions (Central Asia & Russia, East Asia, Europe, Middle East, North America, South Africa, South America, and Southeast Asia). Serious procedure-related adverse events (SAEs) were evaluated in a subset of patients with ≥ 7 days of follow-up.

RESULTS

A total of 3,680 patients undergoing initial PVI for AF were included. Cryoballoon ablation was commonly performed in patients with paroxysmal AF. Mean age ranged from 47 ± 12 years in the Middle East to 64 ± 11 years in East Asia. Mean procedure time was ≤ 95 min in all regions. Average freeze duration ranged from 153 ± 41 s in Southeast Asia to 230 ± 29 s in Central Asia & Russia. Acute procedural success was ≥ 94.7% in all geographies. In 3,126 subjects with ≥ 7 days of follow-up, 122 procedure-related SAEs were reported in 111 patients (3.6%) and remained low in all regions. One procedure-related death was reported during data collection.

CONCLUSIONS

Despite regional variations in patient selection and procedural characteristics, PVI using cryoballoon ablation was performed with high acute success and short procedural times around the world.

CLINICAL TRIAL REGISTRATION

https://clinicaltrials.gov/ct2/show/NCT02752737.

摘要

背景

冷冻球囊消融术是一种成熟的解剖学方法,用于治疗心房颤动(AF)患者的肺静脉隔离(PVI)。尽管该技术已被广泛采用,但在护理标准方面的区域差异尚未得到充分描述。

方法

从 2016 年 5 月至 2021 年 9 月,在 37 个国家的 128 个地点,根据当地临床实践,对符合条件的 AF 患者进行 Cryo Global Registry(NCT02752737)登记,并使用冷冻球囊消融术进行治疗。总结了 8 个地区(中亚和俄罗斯、东亚、欧洲、中东、北美、南非、南美和东南亚)的患者基线特征和手术特征。对≥7 天随访的部分患者进行严重手术相关不良事件(SAE)评估。

结果

共纳入 3680 例接受初始 PVI 的 AF 患者。冷冻球囊消融术常用于治疗阵发性 AF 患者。中东地区患者的平均年龄为 47±12 岁,东亚地区患者的平均年龄为 64±11 岁。所有地区的平均手术时间均≤95 分钟。平均冷冻时间在东南亚为 153±41 秒,在中亚和俄罗斯为 230±29 秒。所有地区的即刻手术成功率均≥94.7%。在 3126 例随访≥7 天的患者中,111 例(3.6%)报告了 122 例与手术相关的 SAE,所有地区的 SAE 发生率均较低。在数据收集期间报告了 1 例与手术相关的死亡。

结论

尽管在患者选择和手术特征方面存在区域性差异,但全球范围内使用冷冻球囊消融术进行 PVI 操作具有较高的即刻成功率和较短的手术时间。

临床试验注册

https://clinicaltrials.gov/ct2/show/NCT02752737。